期刊
JOURNAL OF INVESTIGATIVE DERMATOLOGY
卷 133, 期 1, 页码 239-248出版社
ELSEVIER SCIENCE INC
DOI: 10.1038/jid.2012.245
关键词
-
类别
资金
- Ministerio de Ciencia y Tecnologia of the Spanish Government [PI06/0655, SAF2010-22156, PI10/01480]
- CIEMAT
Nonmelanoma skin cancer (NMSC) is by far the most frequent type of cancer in humans. NMSC includes several types of malignancies with different clinical outcomes, the most frequent being basal and squamous cell carcinomas. We have used the Sleeping Beauty transposon/transposase system to identify somatic mutations associated with NMSC. Transgenic mice bearing multiple copies of a mutagenic Sleeping Beauty transposon T2Onc2 and expressing the SB11 transposase under the transcriptional control of regulatory elements from the keratin K5 promoter were treated with TPA, either in wild-type or Ha-ras mutated backgrounds. After several weeks of treatment, mice with transposition developed more malignant tumors with decreased latency compared with control mice. Transposon/transposase animals also developed basal cell carcinomas. Genetic analysis of the transposon integration sites in the tumors identified several genes recurrently mutated in different tumor samples, which may represent novel candidate cancer genes. We observed alterations in the expression levels of some of these genes in human tumors. Our results show that inactivating mutations in Notch1 and Nsd1, among others, may have an important role in skin carcinogenesis. Journal of Investigative Dermatology (2013) 133, 239-248; doi:10.1038/jid.2012.245; published online 26 July 2012
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据